Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Fluidnet raises $25 million
You may also be interested in...
Assurance Cases Are Slowing Down Infusion Pump Submissions, Branch Chief Says
The need for infusion pump manufacturers to prepare safety cases is slowing down 510(k) submissions for the products, said Richard Chapman, the head of CDRH's General Hospital Devices review branch.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.